Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.9%

1 terminated/withdrawn out of 54 trials

Success Rate

92.9%

+6.4% vs industry average

Late-Stage Pipeline

17%

9 trials in Phase 3/4

Results Transparency

0%

0 of 13 completed trials have results

Key Signals

14 recruiting

Enrollment Performance

Analytics

N/A
16(48.5%)
Phase 2
8(24.2%)
Phase 3
5(15.2%)
Phase 4
4(12.1%)
33Total
N/A(16)
Phase 2(8)
Phase 3(5)
Phase 4(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (54)

Showing 20 of 54 trials
NCT07507825Phase 2Not Yet Recruiting

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Role: collaborator

NCT06792786Not ApplicableRecruiting

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Role: lead

NCT07089862Not ApplicableRecruiting

INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)

Role: collaborator

NCT07413809Phase 3Recruiting

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Role: collaborator

NCT07177586Not ApplicableRecruiting

New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask Airway

Role: collaborator

NCT06092671Not ApplicableRecruiting

Effect of FPCA on Incidence of Emergency Delirium in Children After Surgery

Role: collaborator

NCT06462313Not ApplicableCompleted

Dobutamine for Management of Surgical Patients With Septic Shock

Role: collaborator

NCT06520163Phase 3Recruiting

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

Role: collaborator

NCT04694248Not ApplicableRecruiting

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Role: collaborator

NCT07078500Phase 2Recruiting

Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma

Role: collaborator

NCT07014345Not ApplicableWithdrawn

Double-Lumen Tube Intubation in the Lateral Position Versus the Supine Position on First-Attempt Success Rate

Role: collaborator

NCT06955143Recruiting

A Study on the Peripheral Blood in Patients With Acute Coronary Syndrome

Role: collaborator

NCT07022223Phase 2Recruiting

Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma

Role: collaborator

NCT06987760Not ApplicableRecruiting

Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones

Role: collaborator

NCT05482230Not ApplicableCompleted

Application of Tracheal Intubation in Lateral Position in Thoracic Surgery

Role: collaborator

NCT06012760Not ApplicableRecruiting

The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion

Role: collaborator

NCT06925334Phase 4Enrolling By Invitation

A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus

Role: collaborator

NCT06709144Phase 3Active Not Recruiting

Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer

Role: collaborator

NCT04546360Completed

Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

Role: collaborator

NCT06520176Phase 3Recruiting

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Role: collaborator